Atlas Trials

First-line Metastatic Pancreatic Cancer : FOLFIRINOX +/- LV5FU2 in Maintenance Versus Firgem

Clinical trial NCT02352337 · COMPLETED

Trial details

NCT number
NCT02352337
Sponsor
Federation Francophone de Cancerologie Digestive
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Metastatic Pancreatic Cancer
Start date
2015-01-12
Primary completion
2017-12-01
Enrollment
276

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.